Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial

Journal:

The Lancet Oncology

Published:

2025-12-24

DOI:

10.1016/s1470-2045(25)00614-x

Affiliations:

43

Authors:

41

Go to article

Institutions	Authors	Share
Erasmus MC Cancer Institute, Netherlands	6.000000	0.15
European Organisation for Research and Treatment of Cancer (EORTC), Belgium	3.000000	0.07
Alfred Hospital, Australia	1.000000	0.02
University Hospital Bonn (UKB), Uni Bonn, Germany	1.000000	0.02
The Christie NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Mayo Clinic, United States of America (USA)	1.000000	0.02
The University of Sydney (USYD), Australia	1.000000	0.02
Erasmus University Medical Center (Erasmus MC), Netherlands	1.000000	0.02
University Hospitals Leuven (UZ Leuven), Belgium	1.000000	0.02
University Hospital Saint-Luc, Belgium	1.000000	0.02
Radboud University Medical Centre (Radboudumc), RU, Netherlands	1.000000	0.02
University Hospital of Regensburg (UKR), Germany	1.000000	0.02
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	1.000000	0.02
Derriford Hospital, United Kingdom (UK)	1.000000	0.02
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.02
NIH NCI Center for Cancer Research (CCR), United States of America (USA)	1.000000	0.02
Geneva University Hospitals (HUG), Switzerland	1.000000	0.02
Brain and Spine Institute (ICM), France	1.000000	0.02
Amsterdam UMC, Netherlands	1.000000	0.02
University Hospital of Cologne, Germany	1.000000	0.02
Institute Gustave-Roussy (IGR), France	1.000000	0.02
National Center for Tumor Diseases (NCT) Heidelberg, Germany	1.000000	0.02
Yale University, United States of America (USA)	1.000000	0.02
University Hospital Zurich (UHZ), Switzerland	1.000000	0.02
Centre Eugène Marquis (CEM), France	1.000000	0.02
IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB), Italy	1.000000	0.02
Nottingham University Hospitals NHS Trust (NUH), United Kingdom (UK)	1.000000	0.02
University Medical Center Groningen (UMCG), RUG, Netherlands	1.000000	0.02
Northern Sydney Local Health District (NSLHD), Australia	0.500000	0.01
University of Turin (UNITO), Italy	0.500000	0.01
A.O.U. Citta della Salute e della Scienza di Torino, Italy	0.500000	0.01
Institut de Neurophysiopathologie (INP), France	0.500000	0.01
Hospital Timone, France	0.500000	0.01
Amsterdam UMC, Location VUmc, Netherlands	0.500000	0.01
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands	0.500000	0.01
The University of Western Australia (UWA), Australia	0.500000	0.01
Western General Hospital, NHS Lothian, United Kingdom (UK)	0.500000	0.01
The University of Edinburgh, United Kingdom (UK)	0.500000	0.01
MAASTRO Clinic, Netherlands	0.333333	0.01
Maastricht University Medical Center+ (Maastricht UMC+), Netherlands	0.333333	0.01
Kantonsspital Graubünden, Switzerland	0.333333	0.01

Interested in Oncology and Carcinogenesis?